Abstract
The development of cancer metastases is multifactorial and can be affected by a wide range of host, cell, and tissue-microenvironment factors. A crucial cellular event by which primary cancer cells invade neighboring tissue structures and distant organs involves the acquisition of autonomous motile and invasive properties; these can be inherent to a specific cancer cell variant, possibly cancer stem-cell type, or can be acquired during the course of tumor progression. Several transmembrane receptors, focal contact proteins, cell cytoskeleton and motor proteins, and intracellular signaling molecules converge to regulate cell migration and invasion. In particular, great research efforts have pinpointed the central role of focal adhesion dynamics and turnover within distinct subcellular compartments in the regulation of cell traction and retraction forces that drive, essential cell locomotion and invasion of neighboring tissues. Of clinical relevance, several components of the signaling pathways that regulate focal adhesion trafficking and turnover are deregulated in human cancer tissues; overexpression and hyperactivation are more common in invasive cancers compared to benign disease. This chapter provides the reader with an abridged, updated, and clinically relevant overview of signaling pathways that regulate trafficking and turnover of focal adhesion proteins involved in cancer cell migration and invasion. Potential clinical implications of specific proteins that can be exploited as biomarkers and therapeutic targets for the management of metastatic disease are emphasized. For detailed molecular biology of trafficking signaling, we refer the reader to selected seminal reviews in the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- TGN:
-
trans-golgi network
- G:
-
Golgi
- FA:
-
focal adhesion
- ER:
-
endoplasmic reticulum
- N:
-
nucleus
- PM:
-
plasma membrane
- ECM:
-
extracellular matrix
- LE:
-
late endosome
- EE:
-
early endosome
- RE:
-
recycling endosome
- Lys:
-
lysosome
References
Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K. Molecular characterization of the cancer microenvironment in breast cancer. Cancer Cell 2004; 6(1): 17–32.
Anderson TW, Vaughan AN, Cramer LP. Retrograde flow and myosin II activity within the leading cell edge deliver F-actin to the lamella to seed the formation of graded polarity actomyosin II filament bundles in migrating fibroblasts. Mol. Biol. Cell 2008; 19(11): 5006–5018.
Beadle C, Assanah MC, Monzo P, Vallee R, Rosenfeld SS, Canoll P. The role of myosin II in glioma invasion of the brain. Mol. Biol. Cell 2008; 19(8): 3357–3368.
Behmoaram E, Bijian K, Jie S, Xu Y, Darnel A, Bismar TA, Alaoui-Jamali MA. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. Am. J. Pathol. 2008; 173(5): 1540–1550.
Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat. Rev. Cancer 2009; 9(2): 108–122. Review.
Cantalupo G, Alifano P, Roberti V, Bruni CB, Bucci C. Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes. EMBO J. 2001; 20(4): 683–693.
Caswell PT, Vadrevu S, Norman JC. Integrins: masters and slaves of endocytic transport. Nat. Rev. Mol. Cell Biol. 2009; 10(12): 843–853.
Caswell PT, Spence HJ, Parsons M, White DP, Clark K, Cheng KW, Mills GB, Humphries MJ, Messent AJ, Anderson KI, McCaffrey MW, Ozanne BW, Norman JC. Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev. Cell 2007; 13(4): 496–510.
Caswell PT, Chan M, Lindsay AJ, McCaffrey MW, Boettiger D, Norman JC. Rab-coupling protein coordinates recycling of alpha5beta1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J. Cell Biol. 2008; 183(1): 143–155.
Chardin P, McCormick F. Brefeldin A: the advantage of being uncompetitive. Cell 1999; 97(2): 153–155.
Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N, Liu J, Smith-McCune K, Lu KH, Fishman D, Gray JW, Mills GB. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 2004; 10(11): 1251–1256.
Cheng KW, Lahad JP, Gray JW, Mills GB. Emerging role of RAB GTPases in cancer and human disease. Cancer Res. 2005; 65(7): 2516–2519.
Chibalina MV, Puri C, Kendrick-Jones J, Buss F. Potential roles of myosin VI in cell motility. Biochem. Soc. Trans. 2009; 37(Pt 5): 966–970.
Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat. Rev. Cancer 2003; 3(12): 921–930.
Corbeel L, Freson K. Rab proteins and Rab-associated proteins: major actors in the mechanism of protein-trafficking disorders. Eur. J. Pediatr. 2008; 167(7): 723–729.
Dulyaninova NG, Malashkevich VN, Almo SC, Bresnick AR. Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation. Biochemistry 2005; 44(18): 6867–6876.
Dunphy JL, Moravec R, Ly K, Lasell TK, Melancon P, Casanova JE. The Arf6 GEF GEP100/BRAG2 regulates cell adhesion by controlling endocytosis of beta1 integrins. Curr. Biol. 2006; 16(3): 315–320.
Eathiraj S, Mishra A, Prekeris R, Lambright DG. Structural basis for Rab11-mediated recruitment of FIP3 to recycling endosomes. J. Mol. Biol. 2006; 364(2): 121–135.
Echard A, Jollivet F, Martinez O, Lacapère JJ, Rousselet A, Janoueix-Lerosey I, Goud B. Interaction of a Golgi-associated kinesin-like protein with Rab6. Science 1998; 279(5350): 580–585.
Elliott PJ, Ross JS. The proteasome: a new target for novel drug therapies. Am. J. Clin. Pathol. 2001; 116(5): 637–646.
Etienne-Manneville S, Hall A. Cell polarity: Par6, aPKC and cytoskeletal crosstalk. Curr. Opin. Cell Biol. 2003; 15(1): 67–72.
Ezratty EJ, Partridge MA, Gundersen GG. Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. Nat. Cell Biol. 2005; 7(6): 581–590.
Farnsworth CC, Seabra MC, Ericsson LH, Gelb MH, Glomset JA. Rab geranylgeranyl transferase catalyzes the geranylgeranylation of adjacent cysteines in the small GTPases Rab1A, Rab3A, and Rab5A. Proc. Natl. Acad. Sci. USA 1994; 91(25): 11963–11967.
Folkman J, Kalluri R. Cancer without disease. Nature 2004; 427(6977): 787.
Friedland JC, Lee MH, Boettiger D. Mechanically activated integrin switch controls alpha5beta1 function. Science 2009; 323(5914): 642–644.
Fukui K, Tamura S, Wada A, Kamada Y, Igura T, Kiso S, Hayashi N. Expression of Rab5a in hepatocellular carcinoma: possible involvement in epidermal growth factor signaling. Hepatol. Res. 2007; 37(11): 957–965.
Geiger B, Bershadsky A, Pankov R, Yamada KM. Transmembrane crosstalk between the extracellular matrix—cytoskeleton crosstalk. Nat. Rev. Mol. Cell Biol. 2001; 2(11): 793–805.
Gundersen GG, Bretscher A. Cell biology. Microtubule asymmetry. Science 2003; 300(5628): 2040–2041.
Hammer, JA, Wu XS. Rabs grab motors: defining the connections between Rab GTPases and motor proteins. Curr. Opin. Cell Biol. 2002; 14(1): 69–75.
Helms JB, Rothman JE. Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature 1992; 360(6402): 352–354.
Hervy M, Hoffman L, Beckerle MC. From the membrane to the nucleus and back again: bifunctional focal adhesion proteins. Curr. Opin. Cell Biol. 2006; 18(5): 524–532.
Hirschberg K, Miller CM, Ellenberg J, Presley JF, Siggia ED, Phair RD, Lippincott-Schwartz J. Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J. Cell Biol. 1998; 143(6): 1485–1503.
Ho WT, Exton JH, Williger BT. Arfaptin 1 inhibits ADP-ribosylation factor-dependent matrix metalloproteinase-9 secretion induced by phorbol ester in HT 1080 fibrosarcoma cells. FEBS Lett. 2003; 537(1–3): 91–95.
Hoffman BD, Crocker JC. Cell mechanics: dissecting the physical responses of cells to force. Annu. Rev. Biomed. Eng. 2009; 11: 259–288.
Hoeller D, Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009; 458(7237): 438–444.
Hoeller D, Hecker CM, Dikic I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat. Rev. Cancer 2006; 6(10): 776–788.
Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2002; 2: 91–100.
Hooper S, Gaggioli C, Sahai E. A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion. Br. J. Cancer 2010; 102: 392–402.
Horgan CP, McCaffrey MW. The dynamic Rab11-FIPs. Biochem. Soc. Trans. 2009; 37(Pt 5): 1032–1036.
Ilić D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995; 377(6549): 539–544.
Ilić D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto J, Okada M, Yamamoto T. Interaction of a Golgi-associated kinesin-like protein with Rab6. Science 1998; 279(5350): 580–585.
Imamura H, Takaishi K, Nakano K, Kodama A, Oishi H, Shiozaki H, Monden M, Sasaki T, Takai Y. Rho and Rab small G proteins coordinately reorganize stress fibers and focal adhesions in MDCK cells. Mol. Biol. Cell 1998; 9(9): 2561–2575.
Jackson CL. Mechanisms of transport through the Golgi complex. J. Cell Sci. 2009; 122(Pt 4): 443–452.
Janmey PA, Lindberg U. Cytoskeletal regulation: rich in lipids. Nat. Rev. Mol. Cell Biol. 2004; 5(8): 658–666.
Jones MC, Caswell PT, Norman JC. Endocytic recycling pathways: emerging regulators of cell migration. Curr. Opin. Cell Biol. 2006; 18(5): 549–557.
Jones SM, Howell KE, Henley JR, Cao H, McNiven MA. Role of dynamin in the formation of transport vesicles from the trans-Golgi network. Science 1998; 279(5350): 573–577.
Jordan MA, Wilson L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 1998; 10: 193–230.
Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 2004; 4(4): 253–265.
Jordens I, Westbroek W, Marsman M, Rocha N, Mommaas M, Huizing M, Lambert J, Naeyaert JM, Neefjes J. Rab7 and Rab27a control two motor protein activities involved in melanosomal transport. Pigment Cell Res. 2006; 19(5): 412–423.
Juliano R. Movin’ on through with Cdc2. Nat. Cell Biol. 2003; 5(7): 589–590.
Kelly TA, Kim JA, Patrick R, Grundfest S, Crowe JP. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am. J. Surg. 2003; 186(4): 368–370.
Kim EJ, Helfman DM. Characterization of the metastasis-associated protein, S100A4. Roles of calcium binding and dimerization in cellular localization and interaction with myosin. J. Biol. Chem. 2003; 278(32): 30063–30073.
Krendel M, Mooseker MS. Myosins: tails (and heads) of functional diversity. Physiology (Bethesda) 2005; 20: 239–251.
Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer 2003; 98(10): 2105–2113.
Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84(3): 359–369.
Laukaitis CM, Webb DJ, Donais K, Horwitz AF. Differential dynamics of alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of adhesions in migrating cells. J. Cell Biol. 2001; 153(7): 1427–1440.
Leung KF, Baron R, Seabra MC. Thematic review series: lipid posttranslational modifications. Geranylgeranylation of Rab GTPases. J. Lipid Res. 2006; 47(3): 467–475.
Li Y, Meng X, Feng H, Zhang G, Liu C, Li P. Over-expression of the RAB5 gene in human lung adenocarcinoma cells with high metastatic potential. Chin. Med. Sci. J. 1999; 14(2): 96–101.
Li ZH, Bresnick AR. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res. 2006; 66(10): 5173–5180.
Li ZH, Spektor A, Varlamova O, Bresnick AR. Mts1 regulates the assembly of nonmuscle myosin-IIA. Biochemistry 2003; 42(48): 14258–14266.
Lietha D, Cai X, Ceccarelli DF, Li Y, Schaller MD, Eck MJ. Structural basis for the autoinhibition of focal adhesion kinase. Cell 2007; 129(6): 1177–1187.
Lippincott-Schwartz J, Roberts TH, Hirschberg K. Secretory protein trafficking and organelle dynamics in living cells. Annu. Rev. Cell Dev. Biol. 2000; 16: 557–589.
Lippincott-Schwartz J. Dynamics of secretory membrane trafficking. Ann. N. Y. Acad. Sci. 2004; 1038: 115–124.
Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 2006; 10(6): 839–850.
Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 2003; 83(2): 337–376.
Maxfield FR, McGraw TE. Endocytic recycling. Nat. Rev. Mol. Cell Biol. 2004; 5(2): 121–132.
Mills GB, Jurisica I, Yarden Y, Norman JC. Genomic amplicons target vesicle recycling in breast cancer. J. Clin. Invest. 2009; 119(8): 2123–2127.
Mitra SK, Schlaepfer DD. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 2006; 18(5): 516–523.
Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 2005; 6(1): 56–68.
Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009; 137(3): 433–444.
Mohamed MM, Sloane BF. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 2006; 6(10): 764–775.
Mori Y, Yin J, Sato F, Sterian A, Simms LA, Selaru FM, Schulmann K, Xu Y, Olaru A, Wang S, Deacu E, Abraham JM, Young J, Leggett BA, Meltzer SJ. Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning. Cancer Res. 2004; 64(7): 2434–2438.
Mosesson Y, Mills GB, Yarden Y. Derailed endocytosis: an emerging feature of cancer. Nat. Rev. Cancer 2008; 8(11): 835–850.
Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat. Rev. Cancer 2004; 4(6): 448–456.
Pantel K, Woelfle U. Micrometastasis in breast cancer and other solid cancers. J. Biol. Regul. Homeost. Agents 2004; 18(2): 120–125.
Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005; 8(3): 241–254.
Pei L, Peng Y, Yang Y, Ling XB, Van Eyndhoven WG, Nguyen KC, Rubin M, Hoey T, Powers S, Li J. PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. Cancer Res. 2002; 62(19): 5420–5424.
Pelkmans L, Fava E, Grabner H, Hannus M, Habermann B, Krausz E, Zerial M. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 2005; 436(7047): 78–86.
Pellinen T, Ivaska J. Integrin traffic. J. Cell Sci. 2006; 119(Pt 18): 3723–3731.
Pellinen T, Arjonen A, Vuoriluoto K, Kallio K, Fransen JA, Ivaska J.. Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of beta1-integrins. J. Cell Biol. 2006; 173(5): 767–780.
Pellinen T, Tuomi S, Arjonen A, Wolf M, Edgren H, Meyer H, Grosse R, Kitzing T, Rantala JK, Kallioniemi O, Fässler R, Kallio M, Ivaska J. Integrin trafficking regulated by Rab21 is necessary for cytokinesis. Dev. Cell 2008; 15(3): 371–385.
Pereira-Leal JB, Seabra MC. The mammalian Rab family of small GTPases: definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily. J. Mol. Biol. 2000; 301(4): 1077–1087.
Pereira-Leal JB, Seabra MC. Evolution of the Rab family of small GTP-binding proteins. J. Mol. Biol. 2001; 313(4): 889–901.
Petrie RJ, Doyle AD, Yamada KM. Random versus directionally persistent cell migration. Nat. Rev. Mol. Cell Biol. 2009; 10(8): 538–549.
Powelka AM, Sun J, Li J, Gao M, Shaw LM, Sonnenberg A, Hsu VW. Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic 2004; 5(1): 20–36.
Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid cancers. Nat. Genet. 2003; 33(1): 49–54.
Revenu C, Athman R, Robine S, Louvard D. The co-workers of actin filaments: from cell structures to signals. Nat. Rev. Mol. Cell Biol. 2004; 5(8): 635–646.
Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. Cell migration: integrating signals from front to back. Science 2003 5; 302(5651): 1704–1709.
Riethmuller G, Klein CA. Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin. Cancer Biol. 2001; 11(4): 307–311.
Ring A, Smith IE, Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol. 2004; 5(2): 79–88.
Sandquist JC, Means AR. The C-terminal tail region of nonmuscle myosin II directs isoform-specific distribution in migrating cells. Mol. Biol. Cell 2008; 19(12): 5156–5167.
Scapin SM, Carneiro FR, Alves AC, Medrano FJ, Guimarães BG, Zanchin NI. The crystal structure of the small GTPase Rab11b reveals critical differences relative to the Rab11a isoform. J. Struct. Biol. 2006; 154(3): 260–268.
Schimmöller F, Simon I, Pfeffer SR. Rab GTPases, directors of vesicle docking. J. Biol. Chem. 1998; 273(35): 22161–22164.
SeabraMC, Wasmeier C. Controlling the location and activation of Rab GTPases. Curr. Opin. Cell Biol. 2004; 16(4): 451–457.
Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N, Tanzawa H. Aberrant expression of RAB1A in human tongue cancer. Br. J. Cancer 2005; 92(10): 1915–1921.
Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2000; 2(5): 249–256.
Sorkin A, Goh LK. Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking. Exp. Cell Res. 2009; 315(4): 683–696.
Stenmark, H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 2009; 10(8): 513–525.
Stenmark H, Olkkonen VM. The Rab GTPase family. Genome Biol. 2001; 2(5): S3007. Review.
Tang BL, Ng EL. Rabs and cancer cell motility. Cell Motil. Cytoskel. 2009; 66(7): 365–370.
Torres VA, Mielgo A, Barilà D, Anderson DH, Stupack D. Caspase 8 promotes peripheral localization and activation of Rab5. J. Biol. Chem. 2008; 283(52): 36280–36289.
Upla P, Marjomäki V, Kankaanpää P, Ivaska J, Hyypiä T, Van Der Goot FG, Heino J. Clustering induces a lateral redistribution of alpha 2 beta 1 integrin from membrane rafts to caveolae and subsequent protein kinase C-dependent internalization. Mol. Biol. Cell 2004; 15(2): 625–636.
van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 2002; 347(25): 1999–2009.
van Nimwegen MJ, van de Water B. Focal adhesion kinase: a potential target in cancer therapy. Biochem. Pharmacol. 2007; 73(5): 597–609.
Vicente-Manzanares M, Koach MA, Whitmore L, Lamers ML, Horwitz AF. Segregation and activation of myosin IIB creates a rear in migrating cells. J. Cell Biol. 2008; 183(3): 543–554.
Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 2009; 10(11): 778–790.
Wang JS, Wang FB, Zhang QG, Shen ZZ, Shao ZM. Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Mol. Cancer Res. 2008; 6(3): 372–382.
Weaver DL. Occult “micrometastases” in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy. Cancer 2003; 98(10): 2083–2087.
Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 2004; 6(2): 154–161.
Webb T. Microarray studies challenge theories of metastasis. J. Natl. Cancer Inst. 2003; 95(5): 350–351.
Webb DJ, Parsons JT, Horwitz AF. Adhesion assembly, disassembly and turnover in migrating cells—over and over and over again. Nat. Cell Biol. 2002; 4(4): E97–E100.
Wlodkowic D, Skommer J, McGuinness D, Hillier C, Darzynkiewicz Z. ER-Golgi network—a future target for anti-cancer therapy. Leukemia Res. 2009; 33(11): 1440–1447.
Wyckoff JB, Segall JE, Condeelis JS. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res. 2000; 60(9): 2504–2511.
Wyckoff JB, Segall JE, Condeelis JS. The collection of the motile population of cells from a living tumor. Cancer Res. 2000; 60(19): 5401–5404.
Xu FL, Saunders WS. Actin and microtubules: working together to control spindle polarity. Cancer Cell 2008; 14(3): 197–199.
Yamada H, Abe T, Li SA, Masuoka Y, Isoda M, Watanabe M, Nasu Y, Kumon H, Asai A, Takei K. Dynasore, a dynamin inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments. Biochem. Biophys. Res. Commun. 2009; 390(4): 1142–1148.
Yamana N, Arakawa Y, Nishino T, Kurokawa K, Tanji M, Itoh RE, Monypenny J, Ishizaki T, Bito H, Nozaki K, Hashimoto N, Matsuda M, Narumiya S. The Rho-mDia1 pathway regulates cell polarity and focal adhesion turnover in migrating cells through mobilizing Apc and c-Src. Mol. Cell Biol. 2006; 26(18): 6844–6858.
Yoshida H, Cheng W, Hung J, Montell D, Geisbrecht E, Rosen D, Liu J, Naora H. Lessons from border cell migration in the Drosophila ovary: a role for myosin VI in dissemination of human ovarian cancer. Proc. Natl. Acad. Sci. USA 2004; 101(21): 8144–8149.
Yu X, Miyamoto S, Mekada E.Chang L, Goldman RD. Intermediate filaments mediate cytoskeletal crosstalk. Nat. Rev. Mol. Cell Biol. 2004; 5(8): 601–613.
Zaidel-Bar R, Cohen M, Addadi L, Geiger B. Hierarchical assembly of cell-matrix adhesion complexes. Biochem. Soc. Trans. 2004; 32(Pt3): 416–420.
Zamir E, Katz BZ, Aota S, Yamada KM, Geiger B, Kam Z. Molecular diversity of cell-matrix adhesions. J. Cell Sci. 1999; 112(Pt 11): 1655–1669.
Zerial M, McBride H. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2001; 2(2): 107–117.
Zhang J, Liu X, Datta A, Govindarajan K, Tam WL, Han J, George J, Wong C, Ramnarayanan K, Phua TY, Leong WY, Chan YS, Palanisamy N, Liu ET, Karuturi KM, Lim B, Miller LD. RCP is a human breast cancer-promoting gene with Ras-activating function. J. Clin. Invest. 2009; 119(8): 2171–2183.
Zhu G, Liu J, Terzyan S, Zhai P, Li G, Zhang XC. High resolution crystal structures of human Rab5a and five mutants with substitutions in the catalytically important phosphate-binding loop. J. Biol. Chem. 2003; 278(4): 2452–2460.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Alaoui-Jamali, M.A., Bijian, K., Toliopoulos, P. (2010). Insights into the Dynamics of Focal Adhesion Protein Trafficking in Invasive Cancer Cells and Clinical Implications. In: Wu, WS., Hu, CT. (eds) Signal Transduction in Cancer Metastasis. Cancer Metastasis - Biology and Treatment, vol 15. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9522-0_8
Download citation
DOI: https://doi.org/10.1007/978-90-481-9522-0_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9521-3
Online ISBN: 978-90-481-9522-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)